0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hospital Acquired Infections (HAI) Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-27S5820
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hospital Acquired Infections HAI Diagnostics Market Insights Forecast to 2028
BUY CHAPTERS

Global Hospital Acquired Infections (HAI) Diagnostics Market Research Report 2025

Code: QYRE-Auto-27S5820
Report
September 2025
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hospital Acquired Infections (HAI) Diagnostics Market Size

The global market for Hospital Acquired Infections (HAI) Diagnostics was valued at US$ 3618 million in the year 2024 and is projected to reach a revised size of US$ 4823 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Hospital Acquired Infections (HAI) Diagnostics Market

Hospital Acquired Infections (HAI) Diagnostics Market

Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital Acquired Infections (HAI) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Acquired Infections (HAI) Diagnostics.
The Hospital Acquired Infections (HAI) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hospital Acquired Infections (HAI) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital Acquired Infections (HAI) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hospital Acquired Infections (HAI) Diagnostics Market Report

Report Metric Details
Report Name Hospital Acquired Infections (HAI) Diagnostics Market
Accounted market size in year US$ 3618 million
Forecasted market size in 2031 US$ 4823 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Molecular Diagnostics Tests
  • Other In-vitro Diagnostic Tests
Segment by Application
  • Bloodstream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Surgical Site Infections (SSI)
  • Pneumonia
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BioMérieux, Abbott Laboratories, Roche AG, Siemens Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hospital Acquired Infections (HAI) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hospital Acquired Infections (HAI) Diagnostics Market growing?

Ans: The Hospital Acquired Infections (HAI) Diagnostics Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Hospital Acquired Infections (HAI) Diagnostics Market size in 2031?

Ans: The Hospital Acquired Infections (HAI) Diagnostics Market size in 2031 will be US$ 4823 million.

Who are the main players in the Hospital Acquired Infections (HAI) Diagnostics Market report?

Ans: The main players in the Hospital Acquired Infections (HAI) Diagnostics Market are BioMérieux, Abbott Laboratories, Roche AG, Siemens Healthcare

What are the Application segmentation covered in the Hospital Acquired Infections (HAI) Diagnostics Market report?

Ans: The Applications covered in the Hospital Acquired Infections (HAI) Diagnostics Market report are Bloodstream Infections (BSI), Urinary Tract Infections (UTI), Surgical Site Infections (SSI), Pneumonia, Others

What are the Type segmentation covered in the Hospital Acquired Infections (HAI) Diagnostics Market report?

Ans: The Types covered in the Hospital Acquired Infections (HAI) Diagnostics Market report are Molecular Diagnostics Tests, Other In-vitro Diagnostic Tests

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostics Tests
1.2.3 Other In-vitro Diagnostic Tests
1.3 Market by Application
1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Bloodstream Infections (BSI)
1.3.3 Urinary Tract Infections (UTI)
1.3.4 Surgical Site Infections (SSI)
1.3.5 Pneumonia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2020-2031)
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Region
2.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Hospital Acquired Infections (HAI) Diagnostics Market Dynamics
2.3.1 Hospital Acquired Infections (HAI) Diagnostics Industry Trends
2.3.2 Hospital Acquired Infections (HAI) Diagnostics Market Drivers
2.3.3 Hospital Acquired Infections (HAI) Diagnostics Market Challenges
2.3.4 Hospital Acquired Infections (HAI) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue
3.1.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
3.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio
3.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2024
3.5 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics Head office and Area Served
3.6 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Product and Application
3.7 Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Type
4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2026-2031)
5 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Application
5.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2020-2031)
6.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025)
6.4 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2020-2031)
7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025)
7.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size (2020-2031)
9.2 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioMérieux
11.1.1 BioMérieux Company Details
11.1.2 BioMérieux Business Overview
11.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Introduction
11.1.4 BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
11.1.5 BioMérieux Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
11.2.5 Abbott Laboratories Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Details
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction
11.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
11.3.5 Roche AG Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
11.4.5 Siemens Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Molecular Diagnostics Tests
 Table 3. Key Players of Other In-vitro Diagnostic Tests
 Table 4. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2020-2025)
 Table 8. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2026-2031)
 Table 10. Hospital Acquired Infections (HAI) Diagnostics Market Trends
 Table 11. Hospital Acquired Infections (HAI) Diagnostics Market Drivers
 Table 12. Hospital Acquired Infections (HAI) Diagnostics Market Challenges
 Table 13. Hospital Acquired Infections (HAI) Diagnostics Market Restraints
 Table 14. Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players (2020-2025)
 Table 16. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2024)
 Table 17. Ranking of Global Top Hospital Acquired Infections (HAI) Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Product and Application
 Table 21. Global Key Players of Hospital Acquired Infections (HAI) Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2020-2025)
 Table 25. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Type (2026-2031)
 Table 27. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2020-2025)
 Table 29. Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Application (2026-2031)
 Table 31. North America Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. BioMérieux Company Details
 Table 47. BioMérieux Business Overview
 Table 48. BioMérieux Hospital Acquired Infections (HAI) Diagnostics Product
 Table 49. BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025) & (US$ Million)
 Table 50. BioMérieux Recent Development
 Table 51. Abbott Laboratories Company Details
 Table 52. Abbott Laboratories Business Overview
 Table 53. Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Product
 Table 54. Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025) & (US$ Million)
 Table 55. Abbott Laboratories Recent Development
 Table 56. Roche AG Company Details
 Table 57. Roche AG Business Overview
 Table 58. Roche AG Hospital Acquired Infections (HAI) Diagnostics Product
 Table 59. Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025) & (US$ Million)
 Table 60. Roche AG Recent Development
 Table 61. Siemens Healthcare Company Details
 Table 62. Siemens Healthcare Business Overview
 Table 63. Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Product
 Table 64. Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025) & (US$ Million)
 Table 65. Siemens Healthcare Recent Development
 Table 66. Research Programs/Design for This Report
 Table 67. Key Data Information from Secondary Sources
 Table 68. Key Data Information from Primary Sources
 Table 69. Authors List of This Report


List of Figures
 Figure 1. Hospital Acquired Infections (HAI) Diagnostics Picture
 Figure 2. Global Hospital Acquired Infections (HAI) Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Molecular Diagnostics Tests Features
 Figure 5. Other In-vitro Diagnostic Tests Features
 Figure 6. Global Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2024 VS 2031
 Figure 8. Bloodstream Infections (BSI) Case Studies
 Figure 9. Urinary Tract Infections (UTI) Case Studies
 Figure 10. Surgical Site Infections (SSI) Case Studies
 Figure 11. Pneumonia Case Studies
 Figure 12. Others Case Studies
 Figure 13. Hospital Acquired Infections (HAI) Diagnostics Report Years Considered
 Figure 14. Global Hospital Acquired Infections (HAI) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Hospital Acquired Infections (HAI) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Region: 2024 VS 2031
 Figure 17. Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Players in 2024
 Figure 18. Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Acquired Infections (HAI) Diagnostics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2024
 Figure 20. North America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2020-2031)
 Figure 22. United States Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2020-2031)
 Figure 26. Germany Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Hospital Acquired Infections (HAI) Diagnostics Market Share by Region (2020-2031)
 Figure 34. China Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2020-2031)
 Figure 42. Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Market Share by Country (2020-2031)
 Figure 46. Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Hospital Acquired Infections (HAI) Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. BioMérieux Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
 Figure 50. Abbott Laboratories Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
 Figure 51. Roche AG Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
 Figure 52. Siemens Healthcare Revenue Growth Rate in Hospital Acquired Infections (HAI) Diagnostics Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS